Effects of disease modifying anti-rheumatic agents on class II antigen expression
- PMID: 2785333
- DOI: 10.1007/BF02126593
Effects of disease modifying anti-rheumatic agents on class II antigen expression
Similar articles
-
Stimulatory effects of anti-rheumatic drugs on human neutrophil functions.Immunopharmacology. 1988 Nov-Dec;16(3):157-65. doi: 10.1016/0162-3109(88)90004-5. Immunopharmacology. 1988. PMID: 3150970
-
Effects of auranofin and other antirheumatic drugs on human myelopoiesis in vitro.J Rheumatol. 1987 Apr;14(2):216-20. J Rheumatol. 1987. PMID: 2885415
-
D-penicillamine-induced polymyositis occurring in patients with rheumatoid arthritis: a report of two cases and demonstration of a positive lymphocyte stimulation test to D-penicillamine.Henry Ford Hosp Med J. 1986;34(2):123-6. Henry Ford Hosp Med J. 1986. PMID: 3489699 No abstract available.
-
An alloantibody against a class II antigen subtypic to HLA-DR4 and strongly associated with the cellularly defined Dw14 determinant.Tissue Antigens. 1986 Nov;28(5):313-7. doi: 10.1111/j.1399-0039.1986.tb00501.x. Tissue Antigens. 1986. PMID: 2435018
-
Pathogenesis of Lyme arthritis. Implications for rheumatic disease.Ann N Y Acad Sci. 1988;539:87-92. doi: 10.1111/j.1749-6632.1988.tb31841.x. Ann N Y Acad Sci. 1988. PMID: 3056205 Review. No abstract available.